Fundamental Data for ELOS

SYNERON ME(NSDQ:ELOS)

Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company''s innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications.

# Employees: 280

Address: Industrial Zone Tavor Building PO Box 550,Yokneam Illit,,ISR

Phone: 972 4 909 6200

Fax: 972 4 909 6202

Website: www.syneron.com

Email: infois@syneron.com

Sector: Medical

Industry: MED INSTRUMENTS

Executive Officers

Shimon Eckhouse (Chmn.)

Donald Lee Fagen (Presi.)

Doron Gerstel (C.E.O.)

Fabian Tenenbaum (C.F.O.)

Marshall Butler (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/11/2010

Mean EPS (Next Qtr): ($0.08)

Mean EPS (Year): ($0.74)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 3

Shares Performance

Period	ELOS	Compare to S&P
YTD	22.42 %	1.32 %
4 Weeks	-10.60 %	-11.56 %
12 Weeks	5.26 %	-0.77 %

Shares Information

Analyst Coverage: Y

Avg Volume: 245506

Shares Outstanding: 27M

Market Cap: $0.28B

52 Week High: $12.23

52 Week Low: $4.75

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 ELOS split by factor of 0.000

Earnings Performance

EPS Growth in Last Quarter: 0.00 %

EPS Growth in Last Year: -350.00 %

Sales Growth in Last Quarter: 0.88 %

Sales Growth in Last Quarter: -49.89 %

Financials

Qtr Book Value: $1.21

Cash Flow/Share: $53.29

Change in Payout Ratio: -0.010

Price/Sales: 5.170